| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 118,208 | 109,599 | 126,938 | 274,283 | | Cost of Revenue | 105,024 | 103,906 | 123,512 | 244,568 | | | Gross Profit | 13,184 | 5,693 | 3,426 | 29,715 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,946 | 15,615 | 16,205 | 10,037 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,238 | (9,922) | (12,779) | 19,678 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,011 | 590 | (29) | (1,136) | | Earnings Before Interest And Taxes | 3,249 | (9,332) | (12,808) | 18,542 | | Interest Expense | 3,361 | 1,600 | 1,650 | 2,506 | | Income Before Tax | (112) | (10,932) | (14,458) | 16,036 | | Income Tax Expense | (314) | (2,145) | (2,454) | 5,745 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 202 | (8,787) | (12,004) | 10,291 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (3,604) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 202 | (8,787) | (12,004) | 6,687 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $202 | ($8,787) | ($12,004) | $6,687 |
|
0.51% Nasdaq 
Income Statement
